Literature DB >> 22469261

Gemifloxacin.

Badraddin M H Al-Hadiya1, Ashraf M M Mahmoud.   

Abstract

A comprehensive profile on Gemifloxacin, a novel fluoroquinolone synthetic broad-spectrum antibacterial agent for oral administration, particularly indicated for treatment of community-acquired respiratory tract infections, such as pneumonia and acute bacterial exacerbations of chronic bronchitis, is prepared. This profile contains the following sections: introduction, general physicochemical informations, X-ray powder diffraction patterns, methods of preparations, methods of analysis and stability, spectroscopic methods of investigations, and identifications including ultraviolet/visible spectroscopy, infrared (vibrational) spectroscopy, proton and carbon-13 nuclear magnetic resonance spectrometry, and mass spectrometry. Section 7 includes compendial BP identification methods, thin-layer chromatography, gas chromatography, high performance liquid chromatography. The pharmacological applications section includes uses, mode of action, pharmacokinetics, and toxicity investigations.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Year:  2011        PMID: 22469261     DOI: 10.1016/B978-0-12-387667-6.00004-X

Source DB:  PubMed          Journal:  Profiles Drug Subst Excip Relat Methodol        ISSN: 1871-5125


  1 in total

1.  Polymorphism of antibiotic-inactivating enzyme driven by ecology expands the environmental resistome.

Authors:  Dae-Wi Kim; Cung Nawl Thawng; Jung-Hye Choi; Kihyun Lee; Chang-Jun Cha
Journal:  ISME J       Date:  2017-10-13       Impact factor: 10.302

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.